Lithium

Lithium

SCHEMBL3369766

Cc1ccc(C)c(N=Cc2ccccc2O)c1.[Li]

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 1/20 0.76
▸ MAPT P10636 10/20 0.59
▸ KDM4E B2RXH2 4/20 0.59
▸ KMT2A Q03164 4/20 0.59
▸ ALOX15 P16050 3/20 0.59
▸ THRB P10828 2/20 0.59
▸ PKM P14618 2/20 0.59
▸ LMNA P02545 2/20 0.59
▸ HTT P42858 2/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ HIF1A Q16665 1/20 0.59
▸ CA12 O43570 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ CA9 Q16790 1/20 0.59
▸ ALDH1A1 P00352 7/20 0.58
▸ POLB P06746 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802038 0.98 DHODH (0.78) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL3365283 0.98 DHODH (0.78) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL3369761 0.97 DHODH (0.76) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL3369764 0.97 DHODH (0.76) DHODHMAPTKDM4EKMT2AALOX15
Lithium SCHEMBL3369335 0.88 MAPT (0.76) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL22624746 0.87 MAPT (0.78) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL28759220 0.86 MAPT (0.76) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL3365093 0.86 MAPT (0.78) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL803097 0.86 MAPT (0.78) DHODHMAPTKDM4EKMT2AALOX15
SCHEMBL3369332 0.84 MAPT (0.76) DHODHMAPTKDM4EKMT2AALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9437828-B2 Electroluminescent device using azomethine-lithium-complex as electron injection layer MERCK PATENT GMBH (DE) 2016-09-06 — — US disclosed
US-20150065725-A1 ELECTROLUMINESCENT DEVICE USING AZOMETHINE-LITHIUM-COMPLEX AS ELECTRON INJECTION LAYER MERCK PATENT GMBH (DE) 2015-03-05 — — US disclosed
US-8883325-B2 Electroluminescent device using azomethine-lithium-complex as electron injection layer MERCK PATENT GMBH (DE) 2014-11-11 — — US disclosed
US-20120205638-A1 ELECTROLUMINESCENT DEVICE USING AZOMETHINE-LITHIUM-COMPLEX AS ELECTRON INJECTION LAYER MERCK PATENT GMBH (DE) 2012-08-16 — — US disclosed
US-20100327264-A1 ELECTROLUMINESCENT DEVICE USING AZOMETHINE-LITHIUM-COMPLEX AS ELECTRON INJECTION LAYER MERCK PATNET GMBH (DE) 2010-12-30 — — US disclosed
EP-2095690-B1 ELECTROLUMINESCENT DEVICE USING AZOMETHINE-LITHIUM-COMPLEX AS ELECTRON INJECTION LAYER MERCK PATENT GMBH (DE) 2010-10-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120205638-A1 ELECTROLUMINESCENT DEVICE USING AZOMETHINE-LITHIUM-COMPLEX AS ELECTRON INJECTION LAYER ACSL3, APOL1, INTS9 DHODH 3227/4885MAPT 3539/4885KDM4E 2810/4885
US-20100327264-A1 ELECTROLUMINESCENT DEVICE USING AZOMETHINE-LITHIUM-COMPLEX AS ELECTRON INJECTION LAYER ACSL3, APOL1, INTS9 DHODH 2974/4885MAPT 3581/4885KDM4E 2786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback